Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Eugenia Quiros-Roldan and Isabella Zanella.
Eugenia Quiros-Roldan
Connection Strength
4.857
Isabella Zanella
  1. Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454. Pharmaceuticals (Basel). 2021 Aug 23; 14(8).
    View in: PubMed
    Score: 0.963
  2. C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age. Int J Mol Sci. 2021 06 29; 22(13).
    View in: PubMed
    Score: 0.953
  3. Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals (Basel). 2021 May 11; 14(5).
    View in: PubMed
    Score: 0.945
  4. Letter to the Editor on "Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev". Cytokine Growth Factor Rev. 2020 08; 54:1-2.
    View in: PubMed
    Score: 0.885
  5. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? Pharmacol Res. 2020 08; 158:104904.
    View in: PubMed
    Score: 0.882
  6. Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment. Biomed J. 2021 03; 44(1):43-53.
    View in: PubMed
    Score: 0.228
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.